ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Shares Sold by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC trimmed its holdings in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) by 65.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,321 shares of the company’s stock after selling 10,110 shares during the period. Tower Research Capital LLC TRC owned 2.66% of ProShares UltraShort Nasdaq Biotechnology worth $97,000 as of its most recent filing with the Securities & Exchange Commission.

Separately, Jane Street Group LLC acquired a new stake in ProShares UltraShort Nasdaq Biotechnology in the 3rd quarter valued at about $158,000.

ProShares UltraShort Nasdaq Biotechnology Stock Performance

Shares of ProShares UltraShort Nasdaq Biotechnology stock opened at $21.02 on Friday. The stock’s 50 day simple moving average is $19.10 and its 200-day simple moving average is $17.56. ProShares UltraShort Nasdaq Biotechnology has a 1-year low of $14.05 and a 1-year high of $25.87.

ProShares UltraShort Nasdaq Biotechnology Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Wednesday, March 26th were paid a dividend of $0.1325 per share. This represents a $0.53 dividend on an annualized basis and a yield of 2.52%. The ex-dividend date was Wednesday, March 26th.

ProShares UltraShort Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.